Park, Chang Sin
Yan, Ming https://orcid.org/0000-0001-5116-8290
Zhu, Muye
Akram, Masood A. https://orcid.org/0000-0002-7178-6974
Foster, Nicholas N. https://orcid.org/0000-0003-1740-9788
Bennecke, Andrew
Choi, Christopher https://orcid.org/0000-0003-0410-2488
Marrett, Karl
Moradi, Keivan
Zhang, Jason Y.
Magat, Gabrielle
Nanda, Sumit
Vaca, Raymond https://orcid.org/0000-0002-1720-0741
Wijaya, Kathleen
Zablan, Jedrick Regala
Lee, Sebastian https://orcid.org/0009-0005-8296-558X
Song, Cassidy
Lara, Mary Jasmine https://orcid.org/0009-0008-3737-3907
Louie, Madeline https://orcid.org/0009-0005-5567-8614
Cong, Jason
Kim, Yongsoo https://orcid.org/0000-0002-4277-0279
Ascoli, Giorgio A. https://orcid.org/0000-0002-0964-676X
Langfelder, Peter
Tward, Daniel https://orcid.org/0000-0002-4607-6807
Dong, Hong-Wei https://orcid.org/0000-0001-9972-3177
Yang, X. William https://orcid.org/0000-0003-3705-7935
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (U01MH117079)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (RF1MH128888)
CHDI Foundation
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01NS113612)
Article History
Received: 16 October 2024
Accepted: 8 September 2025
First Online: 31 October 2025
Competing interests
: X.W.Y. has served on scientific advisory boards for Lyterian Therapeutics, Ophidion Therapeutics, Function Rx, Triplet Therapeutics and Mitokinin, Inc. and has consulted for Ionis, Biogen, Novartis, Roche, PTC Therapeutics, Sangamo, LifeEdit, Ascidian, Forbion and ReviR. P.L. serves as an occasional bioinformatics consultant for The Bioinformatics CRO, Inc., Vynance Technologies, LLC and FOXO Technologies, Inc. The other authors declare no competing interests.